Table 3.
Disease-free Survival | Overall Survival | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||||||||
Time ≤ 5 years | Time > 5 years | Time ≤ 5 years | Time > 5 years | |||||||||||||
Univariable Analysis | Multivariable Analysis* | Univariable Analysis | Multivariable Analysis* | Univariable Analysis | Multivariable Analysis* | Univariable Analysis | Multivariable Analysis* | |||||||||
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
| ||||||||||||||||
young Black vs. young White | 1.48 (0.94–2.32) | 0.088 | 1.11 (0.64–1.94) | 0.710 | 1.42 (0.60–3.37) | 0.428 | 1.53 (0.51–4.58) | 0.450 | 1.86 (1.04–3.35) | 0.037 | 1.69 (0.82–3.48) | 0.152 | 0.83 (0.36–1.91) | 0.654 | 0.60 (0.19–1.90) | 0.384 |
| ||||||||||||||||
young Black vs. older Black | 1.23 (0.86–1.76) | 0.264 | 0.91 (0.57–1.45) | 0.690 | 0.33 (0.18–0.60) | <0.001 | 0.32 (0.16–0.64) | 0.001 | 0.95 (0.62–1.46) | 0.817 | 0.88 (0.51–1.51) | 0.643 | 0.23 (0.12–0.44) | <0.001 | 0.17 (0.07–0.41) | <0.001 |
| ||||||||||||||||
young White vs. older White | 1.94 (1.34–2.82) | <0.001 | 1.60 (1.03–2.48) | 0.037 | 0.36 (0.18–0.71) | 0.003 | 0.25 (0.10–0.61) | 0.002 | 1.33 (0.81–2.19) | 0.251 | 1.08 (0.60–1.98) | 0.791 | 0.44 (0.24–0.80) | 0.007 | 0.33 (0.15–0.73) | 0.006 |
| ||||||||||||||||
older Black vs. older White | 2.34 (1.81–3.02) | <0.001 | 1.95 (1.45–2.62) | <0.001 | 1.53 (1.19–2.00) | 0.001 | 1.19 (0.88–1.62) | 0.267 | 2.62 (1.95–3.52) | <0.001 | 2.09 (1.48–2.94) | <0.001 | 1.58 (1.22–2.05) | 0.001 | 1.20 (0.88–1.64) | 0.244 |
Abbreviations: 95% CI, 95% Confidence Interval
adjusted for stage, grade, subtype, and Charlson Comorbidity Index